Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)
Clinical trial NCT05877508 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05877508
- Sponsor
- Michael Peluso, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-07-29
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.